As Medifast INC (MED) Market Valuation Rose, Engaged Capital LLC Cut by $36.23 Million Its Holding

May 18, 2018 - By Lola Flanagan

Medifast, Inc. (NYSE:MED) LogoInvestors sentiment increased to 1.33 in Q4 2017. Its up 0.33, from 1 in 2017Q3. It improved, as 14 investors sold MED shares while 56 reduced holdings. 36 funds opened positions while 57 raised stakes. 10.23 million shares or 0.32% more from 10.20 million shares in 2017Q3 were reported. Victory Mgmt owns 13,541 shares for 0% of their portfolio. Rhumbline Advisers owns 24,902 shares or 0% of their US portfolio. Sei Investments holds 0% or 7,031 shares in its portfolio. Renaissance Technologies Ltd Llc stated it has 956,400 shares or 0.07% of all its holdings. Aperio Grp Incorporated Ltd Company holds 0.02% or 48,958 shares in its portfolio. Meeder Asset Inc stated it has 1,766 shares or 0.01% of all its holdings. 8,350 were reported by State Of Tennessee Treasury Department. Panagora Asset Mngmt holds 1,131 shares. Arizona State Retirement has 17,650 shares. 694,623 were accumulated by Dimensional Fund Advsrs Lp. Ingalls And Snyder Ltd Liability Com accumulated 68,007 shares. Geode Cap Mgmt Ltd Liability reported 0% stake. Cambridge Rech Advsr invested in 5,807 shares. Smith Asset Group Lp reported 1,848 shares stake. Chicago Equity Prtn reported 0.03% of its portfolio in Medifast, Inc. (NYSE:MED).

Since March 8, 2018, it had 0 insider purchases, and 3 selling transactions for $4.87 million activity. MACDONALD MICHAEL C had sold 40,000 shares worth $3.47M on Thursday, March 8.

Glenn W. Welling decreased its stake in Medifast Inc (MED) by 66.49% based on its latest 2017Q4 regulatory filing with the SEC. Engaged Capital Llc sold 525,000 shares as the company’s stock rose 23.31% while stock markets declined. The hedge fund run by Glenn W. Welling held 264,549 shares of the packaged foods company at the end of 2017Q4, valued at $18.47M, down from 789,549 at the end of the previous reported quarter. Engaged Capital Llc who had been investing in Medifast Inc for a number of months, seems to be less bullish one the $1.60 billion market cap company. The stock increased 2.08% or $2.71 during the last trading session, reaching $132.91. About 159,280 shares traded. Medifast, Inc. (NYSE:MED) has risen 107.05% since May 18, 2017 and is uptrending. It has outperformed by 95.50% the S&P500.

Analysts await Medifast, Inc. (NYSE:MED) to report earnings on August, 14. They expect $1.00 earnings per share, up 58.73 % or $0.37 from last year’s $0.63 per share. MED’s profit will be $12.06M for 33.23 P/E if the $1.00 EPS becomes a reality. After $1.01 actual earnings per share reported by Medifast, Inc. for the previous quarter, Wall Street now forecasts -0.99 % negative EPS growth.

Another recent and important Medifast, Inc. (NYSE:MED) news was published by Seekingalpha.com which published an article titled: “Medifast’s (MED) CEO Dan Chard on Q1 2018 Results – Earnings Call Transcript” on May 04, 2018.

Medifast, Inc. (NYSE:MED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: